Ramazan Çakmak

Liv Hospital Topkapı

Endocrinology and Metabolism

Hospital

Choose Department

Before Noon

Afternoon

You must select a hospital to make an appointment.

You can call our Call Center at 444 4 548 for available appointment slots and information.

Areas of Interests

Diabetes
Obesity
Thyroid Diseases
Parathyroid Diseases
Adrenal Gland Diseases
Pituitary Gland Diseases
Osteoporosis
Polycystic Ovary Syndrome (PCOS)

Education:

2004–2010: Istanbul Faculty of Medicine (Çapa) – Medical Education
2011–2015: Istanbul Faculty of Medicine – Residency in Internal Medicine
2016–2020: Istanbul Faculty of Medicine – Sub-specialty Training in Endocrinology and Metabolic Diseases
January 2026: Associate Professorship in Endocrinology and Metabolic Diseases

Experience:

2010–2011: Istanbul Fatih Community Health Center – General Practitioner
2016–2016: Göksun Dr. Süreyya Adanalı State Hospital, Kahramanmaraş – Internal Medicine Specialist
2016–2016: Istanbul Physical Therapy and Rehabilitation Training and Research Hospital – Internal Medicine Specialist
2020–2022: Başakşehir Çam and Sakura City Hospital – Endocrinology Specialist
2022–2024: İstinye University Gaziosmanpaşa Medical Park Hospital – Assistant Professor
2025–2026: Private Şişli Kolan International Hospital – Endocrinology Specialist

1- Comparison of amylase and lipase levels of patients with Type 2 diabetes under different treatment modalities
Ramazan Cakmak, Ozge T Caklili, Sakin Tekin, Hülya Hacisahinogullari, Seher Tanrikulu, Mehmet Sait Koc, Nevin Dinccag. Biomarkers in medicine 3 Dec 2021 doi.org/10.2217/bmm-2021-0318
2- Effects of short-message notifications on type 2 diabetes management in middle-aged Turkish people – A randomized trial (Letter)
Bernard Tahirbegolli, Iliriana Alloqi Tahirbegolli, Ramazan Cakmak, Cemile Idiz, Sabanur Çavdar, Elif Bağdemir, Suphi Vehid.
Balkan Medical Journal, December 2021 DOI : 10.4274/balkanmedj.galenos.2021.2021-10-47
3- Thyroid hormone resistance with succinate dehydrogenase-B gene mutation, a case report
Cansu Erel, Ramazan Cakmak, Hulya Hacisahinogullari, Selay Artan, Ayse Kubat Uzum, Hulya Yazici, Ferihan Aral, Refik Tanakol. Minerva Endocrinol (Torino). 2021 Nov 26. doi: 10.23736/S2724-6507.21.03602-2.
4- Eruptive xanthoma: A marker of hypertriglyceridemia
Ramazan Cakmak, Ozge Telci Caklili, Ozlem Soyluk Selcukbiricik. Journal of Istanbul Faculty of Medicine 84 (4), 36-37
5- The effect of smartphone apps and technology compatibility on diabetes control in diabetic patients using insülin
Mustafa KAHRAMAN, Ramazan ÇAKMAK, İlhan SATMAN, Kubilay KARŞIDAĞ, Şükrü ÖZTÜRK, Meryem Merve ÖREN, Mehmet Akif KARAN.
Journal of Istanbul Faculty of Medicine 84 (4), 543-553
6- What are the factors affecting the frailty of elderly people with type 2 diabetes ?
Cemile İDİZ, Özlem YILMAZ, Nurdan GÜL, Sakin TEKİN, Ramazan ÇAKMAK, Meryem Merve ÖREN, Sena GÜRKAŞ, Mehmet Akif KARA, Gülistan BAHAT, İlhan SATMAN. J Ist Faculty Med 2021;84(1):1-8. doi: 10.26650/IUITFD.2020.0091
7- An endocrinological approach in individuals with gender dysphoria / Cinsiyet hoşnutsuzluğu olan bireylerde endokrinolojik yaklaşım
R Cakmak, AK Uzum. Journal of Istanbul Faculty of Medicine 84 (S1), S17-S17
8- Autoimmune Diseases in Turkish Patients with Type 1 and Type 2 Diabetes: A Single-center Experience
Seher Tanrıkulu, Gülşah Yenidünya Yalın, Ramazan Çakmak, Sakin Tekin, Hülya Hacışahinoğulları, Yıldız Tütüncü, Nurdan Gül, Özlem Soyluk Selçukbiricik, Ayşe Kubat Üzüm, Kubilay Karşıdağ, Nevin Dinççağ, Mehmet Temel Yılmaz, İlhan Satman. Haydarpasa Numune Med J 2021;61(3):346–351 DOI: 10.14744/hnhj.2019.59852
9-Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study)
Tevfik Sabuncu, AlperSonmez, Mehmet Ali Eren, Ibrahim Sahin, Demet Çorapçioğlu, Rıfkı Üçler, Şafak Akin, Cem Haymana, İbrahim Demirci, Ayşegül Atmaca, Halil ÖnderErsözh, İlhanSatman, Fahri Bayram, TEMD Study Group. Primary Care Diabetes 2021; 15(2): 332-329, 1 December 2020 doi.org/10.1016/j.pcd.2020.11.001
10-Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study)
Fahri Bayram, Alper Sonmez, Cem Haymana, Tevfik Sabuncu, Oguzhan Sitki Dizdar, Eren Gurkan, Ayse Kargili Carlioglu, Kemal Agbaht, Didem Ozdemir, Ibrahim Demirci, Cem Barcin, Serpil Salman, Tamer Tetiker, Mustafa Kemal Balci, Nur Kebapci, Canan Ersoy, Volkan Yumuk, Peter P Toth, Ilhan Satman, TEMD Study Group. Lipids Health Dis. 2020 Nov 11;19(1):237. doi: 10.1186/s12944-020-01408-2.
11-A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study
Sonmez A, Tasci I, Demirci I, Haymana C, Barcin C, Aydın H, Cetinalp S, Ozturk FY, Gul K, Sabuncu T, Satman I, Bayram F; TEMD Study Group. Diabetes Ther, 2020 May; 11(5): 1045–1059. doi.org/10.1007/s13300-020-00779-0
12-Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes – A nationwide cross-sectional study (TEMD treatment study)
Cem Haymana, Alper Sonmez, Ibrahim Demirci, Guzin Fidan Yaylalı, Irfan Nuhoglu, Seda Sancak, Murat Yilmaz, Yuksel Altuntas, Nevin Dinccag, Tevfik Sabuncu, Fahri Bayram, Ilhan Satman, TEMD Study Group. Diabetes research and clinical practice, available online 24 november 2020 , volume 171 January 2021 108556 doi.org/10.1016/j.diabres.2020.108556
13-Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data
Rafael Gabriel, Nisa Boukichou Abdelkader, Tania Acosta, Aleksandra Gilis-Januszewska, Ricardo Gómez-Huelgas, Konstantinos Makrilakis, Zdravko Kamenov, Bernhard Paulweber, Ilhan Satman, Predrag Djordjevic, Abdullah Alkandari, Asimina Mitrakou, Nebojsa Lalic, Stephen Colagiuri, Jaana Lindström, Jesús Egido, Andrea Natali, J Carlos Pastor, Yvonne Teuschl, Marcus Lind, Luis Silva, Ruy López-Ridaura, Jaakko Tuomilehto, e-PREDICE Consortium. PLoS One 2020 Apr 13;15(4):e0231196. doi: 10.1371/journal.pone.0231196.
14-Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study).
Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Kıyıcı S, Güldiken S, Örük G, Ozgen Saydam B, Baldane S, Kutlutürk F, Küçükler FK, Deyneli O, Çetinarslan B, Sabuncu T, Bayram F, Satman I; TEMD Study Group. Obes Facts. 2019 Mar 20;12(2):167-178. doi: 10.1159/000496624.
15-The role of kidney injury molecule-1 in predicting cardiorenal syndrome type 1 after diuretic treatment
A Atici, S Emet, ID Toprak, R Cakmak, M Akarsu, T Tukek.
Archives of Medical Sciences, Atherosclerotic Diseasee 2019;4: e208-e214 Published online 2019 aug 15. Doi: 10.5114/amsad.2019.87305
16- Predictive value of global and teritorial longitudinale strain imaging in detecting significant cononary artery disease in patients with myocardial infarction without persistent ST- segment elevation
Adem Atici, Hasan Barman, Eser Durmaz, Koray Demir, Ramazan Cakmak, Sevil Tugrul, Ali Elitok, İmran Onur, İrfan Sahin, Aytac Oncul. Echocardiography. 36(3):512–520, MAR 2019 DOI: 10.1111/echo.14275
17- Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)
Sonmez A, Haymana C, Bayram F, Salman S, Dizdar OS, Gurkan E, Kargili Carlıoglu A, Barcin C, Sabuncu T, Satman I; TEMD Study Group. Diabetes Res Clin Pract. 2018 Dec;146:138-147. doi: 10.1016/j.diabres.2018.09.010.
18- Type 1 cardiorenal syndrome in patients with acutely decompansed heart failure: the importance of new renal biomarkers
A.Atici, S. Emet, R. Cakmak, G. Yuruyen, A. Alibeyoglu, M. Akarsu, Y. Arman, M. Kose, E. Ozgun, M. Ozcan, O. Altun, I. Onur, T. Tukek. Eur Rev Med Pharmacol Sci 2018; 22 (11): 3534-3543, DOI: 10.26355/eurrev_201806_15180
19- Cost-Effectiveness analysis of Type 2 diabetes in outpatient Therapy (Tip 2 Diyabette ayaktan tedavide maliyet etkinlik analizi)
Yuruyen G, Cil E, Arman Y, Demir P, Cakmak R, Akcan T, Ozcan M, Akarsu M, Altun O, Yoldemir S, Kırna K, Toprak D, Tukek T. İst Tıp Fak Derg 2017; 80 (3): 92-7 J Ist Faculty Med 2017;80 (3): 92-7
20- Effect of Glycemic Regulation on Endocan Levels in Patients With Diabetes: A Preliminary Study.
Arman Y, Akpinar TS, Kose M, Emet S, Yuruyen G, Akarsu M, Ozcan M, Yegit O, Cakmak R, Altun O, Aydin S, Alibeyoğlu A, Ugurlu B, Akcan T, Tukek T. Angiology. 2016 Mar;67(3):239-244. doi.org/10.1177/0003319715585664. Epub 2015 May 12
21- Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
Kose M, Emet S, Akpinar TS, Kocaaga M, Cakmak R, Akarsu M, Yuruyen G, Arman Y, Tukek T. Angiology. 2015 Sep;66(8):727-31. doi: 10.1177/0003319714548870. Epub 2014 Aug 28.
22- Rosai-Dorfman disease with diffuse gastrointestinal involvement.
Baran B, Karaca C, Soyer OM, Yonal I, Isiklar AD, Cakmak R, Nalcaci M, Dogan O, Kaymakoglu S. Eur J Gastroenterol Hepatol. 2013 Jul;25(7):869-74. doi: 10.1097/MEG.0b013e32836019f8.
23- COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?
Ramazan ÇAKMAK, Özge TELCİ ÇAKLILI, OK Ayşe, Ümmü MUTLU, Göktuğ SARIBEYLİLER, Vefa SEFEROVA NASİFOVA, Alpay MEDETALİBEYOĞLU, Naci ŞENKAL, Yunus ÇATMA, KOSE Murat
Turk J Diab Obes 2021;3: 279-284. DOI: 10.25048/tudod.959022
24- Malnutrition treatment and follow-up in Clinical Nutrition Outpatient Clinic was associated with increased muscle mass
Bulent Saka, Murat Bektas, Oguz Kagan Bakkaloglu, Shirkhan Amikishiyev, Göktug Sarıbeyliler, Tarık Onur Tiryaki, Burak Ince, Ramazan Cakmak, Serpil Buyukdemir, Bahar Ozmen Senturk, Sebile Nilgun Erten, Mustafa Altınkaynak, Timur Selcuk Akpınar
In Press, Journal Pre-proof, Available online 11 April 2022 doi.org/10.1016/j.nut.2022.111680
25- Genetic investigation of the trail mechanism in diabetic and non-diabetic obese patients
Saadet Busra Aksoyer Sezgin, Sermin Durak, Faruk Celik, Arezoo Gheybi, Murat Diramali, Ramazan Cakmak, Ali Osman Gurol, Ilhan Yaylim, Umit Zeybek
Yayın tarihi, 2024/10, Dergi: Biochemical Genetics
26- A rare cause of dilated cardiomyopathy: hypocalcemia
Archives of Endocrinology and Metabolism 2022-05-13 | Journal article DOI: 10.20945/2359-3997000000474
Ummu Mutlu; Ramazan Cakmak; Mehmet Rasih Sonsöz; Ekrem Bilal Karaayvaz; Ayse Kubat Uzum; Refik Tanakol; Ferihan Aral
27- EUTHYROID SICK SYNDROME: PREVALENCE AND PROGNOSIS IN ELDERLY PATIENTS WITH SEPSIS
Ramazan ÇAKMAK, Adem ATICI, Murat BEKTAŞ, Timur AKPINAR, KOSE Murat, Gülden YÜRÜYEN, Oğuz Kağan BAKKALOĞLU, Tufan TÜKEK
Journal of Istanbul Faculty of Medicine
28-Intravenous high-dose anakinra drops venous thrombosis and acute coronary syndrome in severe and critical COVID-19 patients: a propensity score matched study
R Çakmak, S Yüce, M Ay, MH Uyar, Mİ Kılıç, M Bektaş
Scientific Reports 14 (1), 12369
29- Personalized Treatment Selection and Its Effects on Glycemic Control in Older Adults with Diabetes: A Single Center Experience
Fulya Çalıkoğlu, Damla Guzey, Hülya Hacışahinoğulları, Ramazan Çakmak, AYŞE Kubat Üzüm, Özlem Soyluk Selçukbiricik, Nurdan Gül, Kubilay Karşıdağ, M Yılmaz, Nevin Dinççağ, İlhan Satman
Yayın tarihi, 2024 Dergi: Medical Journal of Bakirkoy
30- Individualized High Dose Intravenous Anakinra Treatment in Cancer Patients with COVID-19 Associated Cytokine Storm: A Retrospective Controlled Study
R Çakmak, M Bektaş
Infectious Diseases & Clinical Microbiology 6 (1),
31- Effect of Sensor-Augmented Patch Pump with Predictive Low-Glucose Suspend Feature Compared to Multiple-Dose Insulin in Patients with Brittle Type 1 Diabetes.
MT Yılmaz, ÖT Çaklılı, H Hacişahinoğulları, R Çakmak, E Şahiner, ...
Endocrinology Research & Practice 27 (2)
32- IL-10, IL-13, IL-17 and CXCL8, CXCL10: Their relationship with the development and prognosis of type 1 and type 2 diabetes
M Ebrahimzadeh, C Pehlivanoglu, BA Ozgur, UC Kucuksezer, ...
Annals of Clinical and Analytical Medicine
33- Malnutrition treatment and follow-up in clinical nutrition outpatient clinics associated with increased muscle mass
B Saka, M Bektas, OK Bakkaloglu, S Amikishiyev, G Sarıbeyliler, ...
Nutrition 101, 111680
34-Exocrine Pancreatic Insufficiency in Diabetes: Association with Cardiovascular Disease and Insulin Therapy
Melek Balamir, Bartu Avcı, Elara Cosan, Sinan Tanyolaç, Bilger Çavus, Aslı Çifcibası Örmeci, Filiz Akyüz, Selman Fatih Beşışık, Sabahattin Kaymakoğlu, Hulya Hacısahinogullari, Göktuğ Sarıbeyliler, Ramazan Çakmak, Kubilay Karşıdağ, Şirin Çetin, Kadir Demir
2026/6/3 ,Journal of Clinical Medicine
35- Investigation of GHRL, REIN, ADIPOQ, NPY and MC4R Gene Polymorphisms in Obese and Non-Obese Patients With Diabetes
SAADET AKSOYER SEZGİN, Şermin DURAK, Faruk Celik, Arezoo Gheybi, Murat Diramali, Ramazan Cakmak, Mustafa Ozyavuz, ALİ GÜROL, Ilhan Yaylim, ÜMİT ZEYBEK
2026, JOURNAL OF ENDOCRINOLOGY AND METABOLISM
36- TETRALOGY OF FALLOT AND SDHB MUTATION AS HYPOXIA-RELATED TRIGGERS OF PARAGANGLIOMA WITH CUTANEOUS VASCULAR MANIFESTATIONS
Ümmü Mutlu, Ezgi Sahin, Ramazan Cakmak, Murat Bektas, Mustafa Altinkaynak, Metban Mastanzade, Emine Göknur Işık, Bengusu Mirasoglu, Tugba Kalayci, Hulya Hacisahinogullari, Gulsah Yenidunya Yalin, Nurdan Gül, Ayse Kubat Uzum, Özlem Soyluk Selçukbiricik
2026/1 , JCEM Case Reports
37- Efficacy of synchronized diabetes monitoring system in patients with type 2 diabetes: Preliminary results of a pilot, randomized clinical trial
Mustafa Kahraman, Ummu Mutlu, Hasan Ediz Ozbek, Elif Beyza Boz, Ramazan Cakmak, Serkan Kurt, Hatice Vildan Dudukcu, Huseyin Yildiz, Mehmet Ali Erturk, Gokhan Ozogur, Hatice Nizam Ozogur, Muhammed Ali Aydin, Nizamettin Aydin, Sukru Ozturk, Kubilay Karsidag, Ilhan Satman, Mehmet Akif Karan
Yayın tarihi, 2025/11/25, Primary Care Diabetes
38- Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study
Sema Hepşen, Cem Haymana, Burçak Cavnar Helvacı, Halil Durantaş, Bora Toros, Ramazan Çakmak, Mehmet Güven, İbrahim Demirci, Lezan Keskin, Sinem Kıyıcı, Zehra Yağmur Şahin Alak, Mehmet Sargın, Gonca Tamer, Damla Balcı, Berna İmge Aydoğan, Arzu Or Koca, Mustafa Aydemir, İlhan Tarkun, Pınar Köksal, Ayten Oğuz, Eda Demir Önal, Süleyman Baldane, Muhammed Kızılgül, Erman Çakal, Bekir Çakır, Şefika Burçak Polat, İlhan Yetkin, Emre Bozkırlı, Gülsüm Karaahmetli, Sevgül Fakı, Narimana Imanova Yaghji, Ayşin Öge, Burak Özbaş, Şenay Topsakal, Sevde Nur Fırat, Hayri Bostan, Barış Karagün, Okan Sefa Bakıner, Ayşe Kargılı Çarlıoğlu, Bahri Evren, Kader Uğur, Faruk Kılınç, Adnan Batman, Selin Çakmak Demir, Dilek Yazıcı, Oğuzhan Deyneli, Metin Arslan, Omercan Topaloğlu, Kübra Kocatepe, Kemal Karagözoğlu, Sakin Tekin, Taner Bayraktaroğlu, Sibel Ertek Yalçın, Ayşe Kubat Üzüm, Gökçem Yalın Kocamaz, Mehtap Şahin, Yusuf Aydın, Mustafa Kutlu, Tevfik Sabuncu, Mustafa Cesur, Volkan Demirhan Yumuk, Fahri Bayram, Alper Sönmez
Yayın tarihi: 2025/10/10, Dergi: European Journal of Medical Research
39- The investigation of leptin (LEP) and leptin receptor (LEPR) gene variations in obese patients
Sermin Durak, Saadet Busra Aksoyer Sezgin, Faruk Celik, Murat Diramali, Ilhan Yaylim, Ali Osman Gurol, Ramazan Cakmak, Umit Zeybek
Yayın tarihi 2025/9/8, Dergi: Clinical & Translational Metabolism
40- A randomised clinical trial to evaluate a digital therapeutic (TH-001) for improving glycaemic control in adults with prediabetes
Ramazan Cakmak, İlker Tosun, Hasan Avcu, Gürkan Caner Birer, Ozer Akgul, Kamal S Saini, Jonathan Carnell, Orkide Kutlu
Yayın tarihi 2025/9, Dergi: Digital Health
41- Successful treatment with rituximab of a type 2 diabetes patient with antibody-mediated insulin resistance syndrome: A case report
Ramazan Çakmak, Sakin Tekin, Hülya Hacişahinoğullari, Ümmü Mutlu, Özge Telci Çaklili, Vefa Seferova Nasibopva, Ayşe Merve Ok, Göktuğ Saribeyliler, Mustafa Araz, Gülşah Yenidünya Yalin, Özlem Soyluk Selçukbiricik, Nurdan Gül, Ayşe Kubat Üzüm, Kubilay Karşidağ, Nevin Dinççağ, Mehmet Temel Yilmaz, İlhan Satman
Yayın tarihi: 2025/7/18, Dergi: Medicine
42- EFFICACY OF SGLT-2 INHIBITORS IN THE TREATMENT OF TYPE 2 DIABETES: SINGLE CENTRE EXPERIENCE TİP 2 DİYABET TEDAVİSİNDE SGLT-2 İNHİBİTÖRLERİNİN ETKİNLİĞİ: TEK MERKEZ DENEYİMİ
Ramazan Çakmak, Golpouneh Oghyanous, Özlem Selçukbiricik, KUBİLAY Karşidağ
Yayın tarihi: 2025, Dergi: Istanbul Tip Fakultesi Dergisi
43- Insulin degludec/insulin aspart (IDegAsp) treatment on glycemic control and weight in patients with insulin experienced uncontrolled type 2 diabetes mellitus: A retrospective observational study
Ramazan Cakmak, Ozge Telci Caklili, Caner Kapar, Yunus Catma, Osman Faruk Bayramlar, Fulya Calikoglu, Kubilay Karsidag, Nevin Dinccag
Yayın tarihi: 2025/1/1, Dergi: Endocrine Regulations
44- Clinical Characteristics and Development of Complications Differ Between Adult‐Onset and Child–Adolescent‐Onset Type 1 Diabetes: A Report From a Tertiary Medical Center in Türkiye
Ramazan Çakmak, Özge Telci Çaklılı, Ayşe Merve Ok, Ümmü Mutlu, Göktuğ Sarıbeyliler, Vefa Seferova Nasifova, Ersel Bilgin, Aylin Çoşkun, Damla Yenersu Guzey, Utku Erdem Soyaltin, Servet Yüce, Hülya Hacışahinoğulları, Gülşah Yenidünya Yalın, Özlem Soyluk Selçukbiricik, Nurdan Gül, Ayşe Kubat Üzüm, Kubilay Karşıdağ, Nevin Dinççağ, Mehmet Temel Yılmaz, Ilhan Satman
Yayın tarihi: 2025, Dergi, Journal of Diabetes Research
45- Automated insulin delivery systems in elderly patients with brittle type 2 diabetes
Ozge Telci Caklili, Ferhat Cetin, Melike Ozkan, Elif Sahiner, Ramazan Cakmak, Ela Keskin, Hulya Hacisahinogullari, Enver Sukru Goncuoglu, M Temel Yilmaz
Yayın tarihi: 2024/12/1, Dergi : Diabetes Research and Clinical Practice
46- Synchronized diabetes monitoring system: development of smart mobile apparatus for diabetes using insulin
Mustafa Kahraman, Hatice Vildan Dudukcu, Serkan Kurt, Huseyin Yildiz, Nizamettin Aydin, Ummu Mutlu, Ramazan Cakmak, Elif Beyza Boz, Hasan Ediz Ozbek, Mehmet Ali Erturk, Gokhan Ozogur, Hatice Nizam Ozogur, Muhammed Ali Aydin, Kubilay Karsidag, Sukru Ozturk, Ilhan Satman, Mehmet Akif Karan
Yayın tarihi, 2024/10/1, Dergi: IRBM